Some readers see this part of your email after the subject line in the inbox. Write something brief and catchy, compelling them to open the email.
Preserving Patient Access is a Patient Safety Issue! 

Let's Protect Patient Access to Life-Saving Compounded Medications!

IACP & DQSA Coalition Host Congressional Briefing 

The  International Academy of Compounding Pharmacists along with the
DQSA Coalition  hosted a Congressional Briefing  at the Rayburn U.S. House of Representatives Office Building in Washington, D.C.

The Objective: to continue educating on the vital need to support patient safety and access to life-saving medications. The panel urged Members of Congress to cosponsor HR 2871: The Preserving Patient Access to Compounded Medications Act of 2017, the bipartisan legislation introduced by Congressmen Morgan Griffith (VA) and Henry Cuellar (TX). The panel shared patients' stories, urged Congress to preserve patient access to vital compounded medications, and discussed the importance of implementing the Drug Quality & Security Act as Congress fully intended.

We were thrilled to host Members of Congress, staff and Capitol Hill-based media reporters, and provided an HR 2871 briefing and information packet  ( background documents and  supporting documents ) to all attendees. 

Congressional staff kicked off the event, discussing why it is so important to support HR 2871: The Preserving Patient Access to Compounded Medications Act of 2017 and why we must Protect Patient Access to
Life-Saving Compounded Medications.
 


Thank you to our incredible  Compounding Speaker Panel, including:
  • Bruce A. Brod, MD, FAAD, American Academy of Dermatology Association (AADA), Chair of the AADA Congressional Policy Committee and past chair of the AADA Drug Pricing and Transparency Task Force.
  • A.J. Day, PharmD, RPh, PCCA, Consultant Pharmacist and Director of Clinical Services in Houston, TX. 
  • Cheri Garvin, RPh, Co-Owner and CEO of The Compounding Center, and a practicing pharmacist for more than 20 years. 
  • Shawn Hodges, PharmD, Owner of Innovation Compounding Pharmacy, IACP Board Member, IACP Legislative Committee Member and IACP COMP PAC Chairman.
  • Mike Koch, RPh, MBA, Senior Vice President of Professional Services, Central Admixture Pharmacy Services (CAPS), responsible for all aspects of the injectable sterile compounding outsourcing service. 
THANK YOU IACP Members  for urging YOUR Members of Congress to attend today, and g etting out the HR 2871 briefing packet (background documents, supporting documents)!   We had an incredible turnout because of YOUR efforts! The room was standing room only and we can't thank YOU and Members of Congress and their staff enough on behalf of patients.
  We Now Have 29 HR 2871 Cosponsors!

Let's keep increasing support  by taking action and getting the word out to Members of Congress on why it's so vital to Protect Patient Access and to Support HR 2871!
IACP | 281.933.8400 |   [email protected] | www.iacprx.org
STAY CONNECTED: